Yokoyama Misa

ヨコヤマミサ | Yokoyama Misa

Affiliation and department：
Job title： Research Associate
Homepage URL (2)： http://db.tohoku.ac.jp/whois/detail/393f430fd8535ce78a0e3180e9fda223.html , http://db.tohoku.ac.jp/whois/e_detail/393f430fd8535ce78a0e3180e9fda223.html
Papers (7)：

Misa Yokoyama, Nobuhiro Tanuma, Rie Shibuya, Takeharu Shiroki, Makoto Abue, Kuniharu Yamamoto, Koh Miura, Kazunori Yamaguchi, Ikuro Sato, Keiichi Tamai, et al. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. International Journal of Oncology. 2018. 52. 3. 881-891
Takeharu Shiroki, Misa Yokoyama, Nobuhiro Tanuma, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya, et al. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism. Cancer Science. 2017. 108. 5. 931-940
Ryuhei Maejima, Keiichi Tamai, Takeharu Shiroki, Misa Yokoyama, Rie Shibuya, Mao Nakamura, Kazunori Yamaguchi, Makoto Abue, Tomoyuki Oikawa, Tetsuya Noguchi, et al. Enhanced expression of semaphorin 3E is involved in the gastric cancer development. INTERNATIONAL JOURNAL OF ONCOLOGY. 2016. 49. 3. 887-894
Makoto Abue, Misa Yokoyama, Rie Shibuya, Keiichi Tamai, Kazunori Yamaguchi, Ikuro Sato, Nobuyuki Tanaka, Shin Hamada, Tooru Shimosegawa, Kazuo Sugamura, et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. INTERNATIONAL JOURNAL OF ONCOLOGY. 2015. 46. 2. 539-547
Keiichi Tamai, Mao Nakamura, Masamichi Mizuma, Mai Mochizuki, Misa Yokoyama, Hiroyuki Endo, Kazunori Yamaguchi, Takayuki Nakagawa, Masaaki Shiina, Michiaki Unno, et al. Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma. CANCER SCIENCE. 2014. 105. 6. 667-674

ｍore...

Awards (2)：

2014/11 - Young Investigator Award ”Pyruvate kinase type M2 (PKM2) is selectively expressed and involved in survival and development in pancreatic ductal adenocarcinomacells”
2013/12 - 日本膵臓病研究財団平成25年度膵臓病研究奨励賞癌間質細胞で発現する Periostin を標的とした膵癌治療法の開発への基礎検討

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page